Yusuke Takeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yusuke Takeda has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Chiaki Nakaseko
Department of Hematology, International University of Health and Welfare, Narita, Japan
2 shared publications - Emiko Sakaida
Department of Hematology, Chiba University Hospital, Chiba, Japan
2 shared publications - Hidetoshi Yamashita
Yamagata City Institute of Public Health, Yamagata, Japan
2 shared publications Masahiko Sugimoto
Department of Ophthalmology and Visual Sciences, Yamagata University Faculty of Medicine, Yamagata, Japan
2 shared publicationsArata Ishii
Department of Hematology, Chiba University Hospital, Chiba, Japan
1 shared publicationAyako Sasaki
Department of Pediatrics, Yamagata University Faculty of Medicine, Yamagata, Japan
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102419
Lupus retinopathy manifesting unilateral neovascular alterations: A case with 15 years of follow-up
- 1 September 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102419
Open AccessLupus retinopathy manifesting unilateral neovascular alterations: A case with 15 years of follow-up
- Open Access
- 1 September 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102427
Spontaneous separation of epiretinal membrane associated with retinal hemangioblastoma: a case report with 10-year follow-up
- 1 September 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102427
Open AccessSpontaneous separation of epiretinal membrane associated with retinal hemangioblastoma: a case report with 10-year follow-up
- Open Access
- 18 January 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (4) , 100715
Prediction Models for Retinopathy of Prematurity Using Nonimaging Machine Learning Approaches: A Regional Multicenter Study
- 18 January 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (4) , 100715
Open AccessPrediction Models for Retinopathy of Prematurity Using Nonimaging Machine Learning Approaches: A Regional Multicenter Study
- Open Access
- 15 March 2022
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 36 (2) , 132-137
Three cases of anomalous posterior segmental vein (V2) in upper lobe of right lung
右上葉の静脈還流は,一般的には肺尖区域静脈(V1),後上葉区域静脈(以下V2),前上葉区域静脈(V3)がV1-V3を形成して上肺静脈に流入するが,稀に破格を認める.今回我々は気管支背側を走行し,上肺静脈根部や左房へ流入するV2の破格を認めた症例を3例経験したので報告する. 症例1-2は右上葉肺癌に対して右上葉切除およびリンパ節郭清を行った.破格のあるV2を確保し,結紮切離した上で右上葉気管支周囲の操作を行った.症例3は右下葉肺癌に対して右下葉切除およびリンパ節郭清を行った.破格のあるV2を確保しテーピングを行うことで,損傷することなく気管分岐下リンパ節郭清を行った.いずれの症例も術前の3 dimension CT(以下3D-CT)にて血管走行の破格を確認し,安全に胸腔鏡下手術を施行した.気管支背側を走行するV2は比較的稀な破格ではあるが,安全を担保する上で念頭に置くべき破格である.
- 15 March 2022
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 36 (2) , 132-137
Open AccessThree cases of anomalous posterior segmental vein (V2) in upper lobe of right lung
右上葉の静脈還流は,一般的には肺尖区域静脈(V1),後上葉区域静脈(以下V2),前上葉区域静脈(V3)がV1-V3を形成して上肺静脈に流入するが,稀に破格を認める.今回我々は気管支背側を走行し,上肺静脈根部や左房へ流入するV2の破格を認めた症例を3例経験したので報告する. 症例1-2は右上葉肺癌に対して右上葉切除およびリンパ節郭清を行った.破格のあるV2を確保し,結紮切離した上で右上葉気管支周囲の操作を行った.症例3は右下葉肺癌に対して右下葉切除およびリンパ節郭清を行った.破格のあるV2を確保しテーピングを行うことで,損傷することなく気管分岐下リンパ節郭清を行った.いずれの症例も術前の3 dimension CT(以下3D-CT)にて血管走行の破格を確認し,安全に胸腔鏡下手術を施行した.気管支背側を走行するV2は比較的稀な破格ではあるが,安全を担保する上で念頭に置くべき破格である.
- Open Access
- 29 October 2021
- Published by Elsevier in Leukemia Research Reports
- Vol. 16, 100278
Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease
- 29 October 2021
- Published by Elsevier in Leukemia Research Reports
- Vol. 16, 100278
Open AccessSuccessful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
1692-P: Ablation of Endothelial ROCK2 Promotes Fat Browning and Improves Metabolic Dysfunction
Intraperitoneal fat is considered a particularly important risk factor for impaired glucose tolerance, dyslipidemia, and coronary heart diseases. However, the underlying mechanisms in obesity are not fully understood. The small GTPase Rho and its downstream effector, Rho-kinase (ROCK), regulate various cellular functions, including organization of the actin cytoskeleton, cell adhesion and expression of genes. Recent studies have shown that Rho/ROCK signaling is strongly related to diabetic vascular complications. ROCK has two isoforms, ROCK1 and ROCK2. Systemic gene deletion studies in mice suggest that these isoforms have distinctive roles in regulating cellular function. In this study, we investigated specific roles of endothelial ROCK2 in the progression of obesity. We mated ROCK2 floxed mice with VE-cadherin-cre mice to generate endothelial-ROCK2 knockout mice (ER2KO). ER2KO mice are resistant to weight gain and glucose intolerance induced by high fat diet. White adipose tissue (WAT) weight was lower in ER2KO mice compared with wild type mice. Histological analysis revealed that adipose droplets were smaller in ER2KO than wild type mice. Browning, the conversion of WAT to a beige phenotype, activates thermogenic function, suppresses obesity and improves glucose and lipid metabolism. Interestingly, we observed an increase of mRNA expression of browning marker including PPARα, CIDEA, PRDM16, UCP1, and specific markers of M2 macrophages in WAT of ER2KO mice regardless of whether they had been fed a normal chow or high fat diet. Collectively, the present study suggests that endothelial ROCK2 regulates glucose and lipid metabolism by suppressing browning of WAT. ROCK2 could be an important therapeutic target against obesity. Disclosure: Y. Takeda: None. K. Matoba: Research Support; Self; Sanofi K.K., Takeda Pharmaceutical Company Limited. D. Kawanami: None. Y. Nagai: None. Y. Kanazawa: None. R. Nishimura: Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc. Speaker’s Bureau; Self; Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Medtronic, Merck & Co., Inc., Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
1692-P: Ablation of Endothelial ROCK2 Promotes Fat Browning and Improves Metabolic Dysfunction
Intraperitoneal fat is considered a particularly important risk factor for impaired glucose tolerance, dyslipidemia, and coronary heart diseases. However, the underlying mechanisms in obesity are not fully understood. The small GTPase Rho and its downstream effector, Rho-kinase (ROCK), regulate various cellular functions, including organization of the actin cytoskeleton, cell adhesion and expression of genes. Recent studies have shown that Rho/ROCK signaling is strongly related to diabetic vascular complications. ROCK has two isoforms, ROCK1 and ROCK2. Systemic gene deletion studies in mice suggest that these isoforms have distinctive roles in regulating cellular function. In this study, we investigated specific roles of endothelial ROCK2 in the progression of obesity. We mated ROCK2 floxed mice with VE-cadherin-cre mice to generate endothelial-ROCK2 knockout mice (ER2KO). ER2KO mice are resistant to weight gain and glucose intolerance induced by high fat diet. White adipose tissue (WAT) weight was lower in ER2KO mice compared with wild type mice. Histological analysis revealed that adipose droplets were smaller in ER2KO than wild type mice. Browning, the conversion of WAT to a beige phenotype, activates thermogenic function, suppresses obesity and improves glucose and lipid metabolism. Interestingly, we observed an increase of mRNA expression of browning marker including PPARα, CIDEA, PRDM16, UCP1, and specific markers of M2 macrophages in WAT of ER2KO mice regardless of whether they had been fed a normal chow or high fat diet. Collectively, the present study suggests that endothelial ROCK2 regulates glucose and lipid metabolism by suppressing browning of WAT. ROCK2 could be an important therapeutic target against obesity. Disclosure: Y. Takeda: None. K. Matoba: Research Support; Self; Sanofi K.K., Takeda Pharmaceutical Company Limited. D. Kawanami: None. Y. Nagai: None. Y. Kanazawa: None. R. Nishimura: Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc. Speaker’s Bureau; Self; Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Medtronic, Merck & Co., Inc., Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.
- Open Access
- 1 January 2013
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 53 (3) , 221-226
Secondary Neurolymphomatosis Detected by Whole-Body Diffusion-Weighted Magnetic Resonance Imaging :A Case Report
Neurolymphomatosis (NL) is a rare clinical entity defined as peripheral nervous system infiltration by lymphoma. The diagnosis is difficult and often elusive. Whole-body diffusion-weighted magnetic resonance imaging (DW MRI) was developed to enhance the detection of vaguely delineated tumors. Here, we describe the case of a 71-year-old male with secondary NL of diffuse large B-cell lymphoma (DLBCL) that was successfully detected by whole-body DW MRI. The patient was diagnosed with DLBCL extending from the ethmoidal sinus to the nasal cavity, orbital cavity, and anterior cranial fossa. Although he was administered R-THP-COP chemotherapy and the tumor remarkably decreased in size, he developed painful paresthesia and weakness in the left upper and bilateral lower extremities during treatment. Because lymphoma cells were detected in his spinal fluid, high-dose methotrexate (MTX) and weekly intrathecal MTX and cytarabine injections were administered. Test results for lymphoma cells in the spinal fluid became negative ; however, the neurological disorders progressed. Whole-body DW MRI was performed as whole-body screening and could localize NL at the left cervical and bilateral lumbar nerve roots. Both cervical spine plain MRI and enhanced computed tomography performed around the same time could not detect the cervical lesion. Our case report suggests that whole-body DW MRI is a useful diagnostic imaging procedure, especially as whole-body screening in facilities where PET/CT is not available. [J Clin Exp Hematop 53(3) : 221-226, 2013]
- 1 January 2013
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 53 (3) , 221-226
Open AccessSecondary Neurolymphomatosis Detected by Whole-Body Diffusion-Weighted Magnetic Resonance Imaging :A Case Report
Neurolymphomatosis (NL) is a rare clinical entity defined as peripheral nervous system infiltration by lymphoma. The diagnosis is difficult and often elusive. Whole-body diffusion-weighted magnetic resonance imaging (DW MRI) was developed to enhance the detection of vaguely delineated tumors. Here, we describe the case of a 71-year-old male with secondary NL of diffuse large B-cell lymphoma (DLBCL) that was successfully detected by whole-body DW MRI. The patient was diagnosed with DLBCL extending from the ethmoidal sinus to the nasal cavity, orbital cavity, and anterior cranial fossa. Although he was administered R-THP-COP chemotherapy and the tumor remarkably decreased in size, he developed painful paresthesia and weakness in the left upper and bilateral lower extremities during treatment. Because lymphoma cells were detected in his spinal fluid, high-dose methotrexate (MTX) and weekly intrathecal MTX and cytarabine injections were administered. Test results for lymphoma cells in the spinal fluid became negative ; however, the neurological disorders progressed. Whole-body DW MRI was performed as whole-body screening and could localize NL at the left cervical and bilateral lumbar nerve roots. Both cervical spine plain MRI and enhanced computed tomography performed around the same time could not detect the cervical lesion. Our case report suggests that whole-body DW MRI is a useful diagnostic imaging procedure, especially as whole-body screening in facilities where PET/CT is not available. [J Clin Exp Hematop 53(3) : 221-226, 2013]